Elanco Animal Health received approval from the Agriculture Department for Befrena, the company's antibody treatment for canine allergic and atopic dermatitis. The animal-medicine company said ...
In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...
In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...
Morning Overview on MSN
A fentanyl vaccine heads to human trials in 2026. Here’s the science
Researchers are closing in on a new kind of protection against the deadliest drug in the United States: a vaccine that trains the immune system to trap fentanyl before it reaches the brain. If early ...
To help protect yourself and your family from getting seriously ill, you may want to learn about additional vaccine options ...
And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...
A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...
See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...
For the second year in a row, the US has surpassed 25,000 whooping cough cases — another sign of the risks of falling ...
The North Texas Region of the Red Cross operates two fixed donation sites in the area: the Irving Blood and Platelet Donation ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback